TXG
10X Genomics IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$2.61B
P/E Ratio
—
EPS
$-0.35
Beta
2.17
52W High
$26.45
52W Low
$7.72
50-Day MA
$21.21
200-Day MA
$16.84
Dividend Yield
—
Profit Margin
-6.77%
Forward P/E
208.33
PEG Ratio
—
About 10X Genomics Inc
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Fundamentals
| Revenue (TTM) | $642.82M |
| Gross Profit (TTM) | $444.38M |
| EBITDA | $-64.09M |
| Operating Margin | -9.42% |
| Return on Equity | -5.78% |
| Return on Assets | -6.40% |
| Revenue/Share (TTM) | $5.15 |
| Book Value | $6.24 |
| Price-to-Book | 3.27 |
| Price-to-Sales (TTM) | 4.05 |
| EV/Revenue | 3.37 |
| EV/EBITDA | 554.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $118.91M |
| Float | $115.88M |
| % Insiders | 1.65% |
| % Institutions | 106.83% |
Historical Volatility
HV 10-Day
83.74%
HV 20-Day
66.81%
HV 30-Day
65.97%
HV 60-Day
72.38%
HV Rank
55.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($24.00 target)
1
Strong Buy5
Buy10
HoldData last updated: 4/30/2026